Paper14501
Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
Atterhög JH and 2 others. Am J Med, 1976. Cited by 69 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension. Papers, record 14501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14501
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Hypertension | Major topic |
| Pindolol | Major topic |
| Blood Pressure | |
| Cardiac Output | |
| Depression, Chemical | |
| Drug Evaluation | |
| Heart Rate | |
| Humans | |
| Middle Aged | |
| Regional Blood Flow | |
| Vascular Resistance |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05882864 | Efficacy of Ginger Muco-bioadhesive Gel in Management of Oral Lichen Planus With Immunohistochemical Analysis | Background |
Source ClinicalTrials.gov
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,653,285 | General Assessment of Indole Derivatives and Wnt Pathway as Potential Key Factors Against Various Diseases, with Particular Emphasis on Thyroid Tumors. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653285 | PubMed |
| 37,511,110 | Artificial Intelligence in Decrypting Cytoprotective Activity under Oxidative Stress from Molecular Structure. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511110 | PubMed |
| 7,104,149 | Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104149 | PubMed |
| 7,104,147 | Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104147 | PubMed |
| 7,049,208 | Pindolol--the pharmacology of a partial agonist. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7049208 | PubMed |
| 6,147,240 | Hypertension in pregnancy. Pathophysiology and management. | Drugs | 1984 | https://conductscience.org/library/papers/6147240 | PubMed |
| 6,125,176 | Effects of beta-adrenoceptor antagonists on central haemodynamics in essential hypertension. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125176 | PubMed |
| 6,125,175 | How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125175 | PubMed |
| 6,125,173 | Peripheral haemodynamic effects of beta-adrenoceptor blocking drugs with ISA or relative beta 1-selectivity at rest and during physical exercise. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125173 | PubMed |
| 6,125,169 | Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125169 | PubMed |
| 3,326,634 | Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3326634 | PubMed |
| 2,894,223 | Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/2894223 | PubMed |
| 2,076,384 | Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2076384 | PubMed |
| 1,747,577 | beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination. | BMJ | 1991 | https://conductscience.org/library/papers/1747577 | PubMed |
| 371,643 | Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients. | Br Heart J | 1979 | https://conductscience.org/library/papers/371643 | PubMed |
| 43,164 | A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/43164 | PubMed |
| 38,968 | Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers. | Eur J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/38968 | PubMed |
| 25,186 | Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/25186 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14501
GET https://conductscience.org/api/papers/v1/14501/authors